MENU

Why the Cochlear Ltd share price is falling on its profit result

The Cochlear Ltd (ASX:COH) share price fell 3% to $166 this morning after the company released its half year results. Revenues at the hearing aid manufacturer grew 6% to $639.6 million, and statutory net profit after tax fell 1% to $110.8 million.

The decline in statutory net profit was due to a $5 million write-off of Cochlear’s deferred tax assets, a side effect of lower US corporate tax rates.

Over the full year, tax asset write-offs are expected to reduce net profit by around $3 million to $4 million, with tax savings starting to make a positive contribution in the second half (the lower tax rate went into effect on 1 January 2018).

From a business perspective, Cochlear’s business performed strongly with the number of units shipped in developed markets growing by 12%.

Units in emerging markets fell, which the company attributed to the timing of tenders, including a Chinese tender awarded in October 2017 that will start shipping in the second half. Currently the company has $107 million cash and cash equivalents in the bank, and has $244 million in debt.

Cochlear gave an outlook for the full year, including a forecast statutory net profit of $240 million to $250 million after currency headwinds are taken into account.

Developed market unit sales are expected to continue growing, with emerging market volume improving thanks to the Chinese tender. Research & Development (R&D) expenditure is expected to be around $160 million to $170 million, compared to $150 million in 2017.

Despite the lower reported earnings, Cochlear increased its dividend 8%, from $1.30 to $1.40 per share. Basic earnings per share were $1.93, pricing Cochlear at more than 40x estimated full year earnings. Using Cochlear’s $240 million profit forecast, the company is currently trading at around 40x full year earnings – a lofty price even for a great business like Cochlear. I like Cochlear a lot, but I think it is fully priced and I’m not a buyer at today’s prices.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Cochlear or REA Group.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor Sean O'Neill has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!